[Synthetic biocompatible degradable material for juvenile bone cyst treatment]

Area of Science:

• Orthopaedic Surgery
• Biomaterials Science
• Paediatric Orthopaedics

Background:

• Juvenile bone cysts are benign, fluid-filled cavities that can compromise bone integrity in children and adolescents.
• Traditional treatments for bone defects often involve invasive procedures and may yield suboptimal results.
• Advances in biocompatible materials offer new avenues for bone defect management.

Purpose of the Study:

• To compare the efficacy of chronOs Inject, a synthetic resorbable material, with Depo-Medrol for treating juvenile bone cysts.
• To evaluate treatment outcomes based on the number of surgical interventions and clinical healing criteria.

Main Methods:

• A comparative study involving patients treated for juvenile bone cysts between 2001 and 2007.
• Group 1 (2001-2003): 24 patients treated with repetitive Depo-Medrol injections.
• Group 2 (2005-2007): 31 patients treated with minimally invasive chronOs Inject.

Main Results:

• The chronOs Inject group achieved 100% cyst healing with a mean of 20 interventions across 18 patients.
• The Depo-Medrol group required 69 applications, with 12 patients (50%) achieving healing without further surgery.
• Significantly fewer operations were needed in the chronOs Inject group.

Conclusions:

• The chronOs Inject method demonstrated superior outcomes compared to Depo-Medrol for juvenile bone cyst treatment.
• Minimally invasive application of chronOs Inject led to significantly better overall results and fewer required surgeries.
• This novel approach addresses limitations of previous treatments for bone defects requiring stabilization.